Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Disposal of Culture Waste – V 2.0

Posted on By


Biosimilars: SOP for Disposal of Culture Waste – V 2.0


Standard Operating Procedure for Disposal of Culture Waste in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/114/2025
Supersedes SOP/BS/114/2022
Page No. Page 1 of 11
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the procedure for biosafety-compliant collection, inactivation, segregation, and disposal of culture waste generated during upstream biosimilar manufacturing processes.

2. Scope

This SOP applies to the handling and disposal of spent cell cultures, used media, residual biomass, contaminated disposables, and effluent generated from bioreactor operations, shake flasks, and seed expansion vessels in the upstream facility.

3. Responsibilities

  • Production Operator: Collect and label culture waste, perform primary inactivation, and record disposal steps.
  • Utility/Engineering: Support effluent neutralization systems and hazardous waste line function.
  • EHS Officer: Verify safe disposal, biosafety compliance, and environmental documentation.

4. Accountability

The Head of Manufacturing is accountable for ensuring culture waste is disposed of in accordance with biosafety, environmental, and regulatory standards.

5. Procedure

5.1 Waste Identification and Segregation

  1. Culture waste is classified as:
    • Liquid waste: spent media, broth, process effluent
    • Solid waste: biomass, filters, tubes, pipettes
  2. Use color-coded bins:
    • Red – biohazardous solids
    • Yellow – sharps/contaminated plastic
    • Blue – autoclaved inert waste

5.2 Inactivation of Liquid Waste

  1. Use thermal inactivation at 121°C for 30 minutes OR
  2. Chemical inactivation using 1% hypochlorite (hold for 1 hour at pH ≥10).
  3. Transfer deactivated liquid to ETP line using labeled hoses.

5.3 Handling of Solid Culture Waste

  1. Place solid waste in autoclavable biohazard bags and seal tightly.
  2. Autoclave at 121°C, 15 psi, 30 minutes in designated autoclave room.
  3. Post-autoclave, tag as “Decontaminated – Safe for Disposal”.
  4. Transport to central bio-waste collection area in leak-proof bins.

5.4 Disposal Documentation

  1. Complete Annexure-1: Culture Waste Disposal Log.
  2. For offsite disposal, coordinate with EHS-approved bio-waste contractor.
  3. Ensure manifest (Annexure-2) is signed by contractor and retained for audit.

5.5 Emergency Handling

  1. If spill occurs, isolate the area immediately.
  2. Apply 1% sodium hypochlorite and absorb with sterile wipes.
  3. Collect as hazardous waste and record incident in deviation log.

6. Abbreviations

  • ETP: Effluent Treatment Plant
  • EHS: Environment, Health and Safety
  • psi: Pounds per square inch

7. Documents

  1. Culture Waste Disposal Log – Annexure-1
  2. Bio-Waste Manifest Record – Annexure-2

8. References

  • WHO TRS 999 Annex 6 – GMP for Biological Products
  • Bio-Medical Waste Management Rules 2016 (India)

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Culture Waste Disposal Log

Date Type Volume/Weight Method Disposed By Verified By
04/05/2025 Liquid 150 L Thermal Sunita Reddy Ajay Verma

Annexure-2: Bio-Waste Manifest Record

Date Bag Count Contractor Name Vehicle No. Signature (Receiver)
04/05/2025 4 CleanMed Services Pvt. Ltd. MH12BC1234 Authorized Agent

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Expanded disposal tracking and added chemical spill response section Compliance update
See also  Biosimilars: SOP for Review and Approval of CLD Protocols - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: API Manufacturing: SOP for Review of Product Labels and Packaging Materials – V 2.0
Next Post: Creams: SOP for Risk Management in Cream Manufacturing Processes – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version